# CSL Limited (CSLLY)

> Source: Nexqual · https://nexqual.com/CSLLY · data as of 2026-10-23 15:23 UTC · cite as "Nexqual, CSL Limited (CSLLY), nexqual.com/CSLLY" · informational, not investment advice.

**Price:** USD 34.53 (+0.61% today) · US market open, as of October 23, 2026 at 15:23 UTC; quotes may be delayed. Prev close 34.32 · day 34.53–34.53 · 52w 16.01–35.64 · market cap $66.3B · OQX

## Key facts
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 34 (range 34–34).
- Total return with dividends: 1Y -0.4% vs S&P 500 +14.4%; 5Y -34.7% vs S&P 500 +77.0%.
- Next earnings: 2026-08-17, EPS estimate USD —, revenue estimate $0K.

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 34 (low 34, high 34).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -0.4% | -34.7% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | -0.4% | -8.2% |
| Volatility (annualized) | 43.6% | 31.7% |
| Max drawdown | -53.5% (Oct 2025→Jun 2026) | -68.8% (Nov 2021→Jun 2026) |

## Peers (Biotechnology)
ARGX (argenx SE) USD 879.41 +0.42% · MRNA (Moderna, Inc.) USD 203.67 +0.51% · REGN (Regeneron Pharmaceuticals, Inc.) USD 806.63 -1.52% · ONC (BeOne Medicines Ltd.) USD 377.05 -1.37% · RVMD (Revolution Medicines, Inc.) USD 188.89 +0.64% · RPRX (Royalty Pharma plc) USD 63.79 +0.05%

## More
Full page: https://nexqual.com/CSLLY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends 2027-06-30) | $1.54 | $1.57 | -2.1% | $15.76B | 1 |
| Next fiscal year (ends 2028-06-30) | $1.68 | $0.00 | — | $16.32B | 1 |